Cargando…
BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
BRCAness is defined as the set of traits in which BRCA1 dysfunction, arising from gene mutation, methylation or deletion, results in DNA repair deficiency. In the present study, we addressed BRCAness, therapeutic efficacy, recurrence, and survival in patients with triple negative breast cancer (TNBC...
Autores principales: | Tanino, Hirokazu, Kosaka, Yoshimasa, Nishimiya, Hiroshi, Tanaka, Youko, Minatani, Naoko, Kikuchi, Mariko, Shida, Akiko, Waraya, Mina, Katoh, Hiroshi, Enomoto, Takumo, Sengoku, Norihiko, Kajita, Sabine, Hoffman, Robert M., Watanabe, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147808/ https://www.ncbi.nlm.nih.gov/pubmed/27935989 http://dx.doi.org/10.1371/journal.pone.0165721 |
Ejemplares similares
-
Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy
por: Kosaka, Yoshimasa, et al.
Publicado: (2015) -
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer
por: Kikuchi, Mariko, et al.
Publicado: (2015) -
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer
por: Minatani, Naoko, et al.
Publicado: (2016) -
Historical progress of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual in patients with breast cancer
por: Kosaka, Yoshimasa, et al.
Publicado: (2019) -
BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
por: Kosaka, Yoshimasa, et al.
Publicado: (2020)